President/CEO
Immunoglobulin National Society
Dr. Luba Sobolevsky is President and Chief Executive Officer of the Immunoglobulin National Society (IgNS), the central, standards-setting healthcare organization in the field of Ig therapy and biologics. Dr. Sobolevsky has over 25 years of diverse leadership experience across the healthcare field, including clinical practice, education, and pharmaceutical industry. She oversees IgNS’ strategic initiatives and development of comprehensive programs and resources that promote best clinical practices and optimal patient outcomes. She is responsible for expanding and improving interdisciplinary and industry-wide collaboration and alliances. Dr. Sobolevsky leads IgNS’ Patient 360 division, dedicated to patient advocacy, education, and outcomes research. She has been actively engaged in research and publication in the areas of optimizing immunoglobulin practice, patient experience, health equity, healthcare team competencies, and improving screening and diagnosis of rare diseases. She holds a PharmD degree from the University of Southern California and a BA from the University of California, Los Angeles.
Disclosure information not submitted.
Monday, March 14, 2022
7:00am – 9:30am CT
